Results 1 to 10 of about 3,414,555 (348)

Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study. [PDF]

, 2015
BackgroundThe US Preventive Services Taskforce (USPSTF) recommends routine lipid screening beginning age 35 for men [1]. For women age 20 and older, as well as men age 20-34, screening is recommended if cardiovascular risk factors are present.
Anderson, Melissa L, Catz, Sheryl L, Fishman, Paul A, Green, Beverly B, Johnson, Ron L, McClure, Jennifer B, Reid, Robert J   +6 more
core   +1 more source

Late Deprescribing of Angiotensin-Converting-Enzyme Inhibitors and Renin-Angiotensin Blockers in Patients with Advanced Cancer Receiving Palliative Care

Palliative Medicine Reports
Background: Treatment with antihypertensives in patients with advanced cancer is often continued until very late in the disease trajectory, despite a considerable risk of hypotension.
Linda Björkhem-Bergman, Christel Hedman, Máté Szilcz, Gabriella Frisk   +3 more
doaj   +1 more source

Drug-induced gingival enlargement: Series of cases

Universidad y Salud, 2018
Introduction: Gingival enlargement (GA) is a benign condition of the oral cavity that is characterized by the excessive growth of the gingiva in mass and volume.
Isabella Manzur-Villalobos, Ivan Alejandro Díaz-Rengifo, Daniella Manzur-Villalobos, Antonio José Díaz-Caballero   +3 more
doaj   +1 more source

Combined antihypertensive medications

Кардиоваскулярная терапия и профилактика, 2007
Arterial hypertension (AH) is one of the most prevalent diseases. Despite impressive progress in studying AH pathogenesis, treatment results should still be improved.
L. L. Kirichenko, A. P. Korolev, S. V. Gatsura, O. B. Golovkova, M. V. Koroleva   +4 more
doaj  

Pharmacogenetic Tests in the Nephrological Clinic

Počki, 2016
Selection of antihypertensive agents using pharmacogenetic tests and individual tolerance is essential in practical nephrology. Antihypertensive first-line drugs are metabolized through various CYP isoforms (CYP2D6, CYP2C9, CYP2C19 and CYP3A4/5).
D.D. Ivanov, O.O. Melnik
doaj   +1 more source

Changes in kidney function in a population with essential hypertension in real life settings [PDF]

, 2017
Introduction. Hypertension has been identified as one of the commonest modifiable determinants for chronic kidney disease progression. A variety of antihypertensive drugs are available and their effect on kidney function has been investigated by a ...
Haidich, Anna-Bettina, Lasaridis, Anastasios N., Mark, Patrick B., Pikilidou, Maria I., Ptinopoulou, Anastasia G., Tziolas, Ioannis M., Zebekakis, Pantelis E.   +6 more
core  

PROBLEMS IN PHARMACOTHERAPY OF RESISTANT ARTERIAL HYPERTENSION

Российский кардиологический журнал, 2013
The paper focuses on the problems in the treatment of patients with resistant arterial hypertension. The relevant recommendations from the European guidelines are presented.
N. V. Teplova, E. O. Taratukhin
doaj   +1 more source

A prospective randomized trial of FK506-based immunosuppression after renal transplantation [PDF]

, 1995
A group of 204 adult patients was entered into a prospective, randomized trial comparing FK506/pred-nisone with FK506/azathioprine/prednisone after renal transplantation between August 1, 1991 and October 11,1992.
Demetris, AJ, Fung, JJ, Hakala, TR, Irish, W, Jordan, ML, McCauley, J, Mitchell, S, Randhawa, P, Scantlebury, VP, Shapiro, R, Simmons, RL, Starzl, TE, Vivas, C   +12 more
core   +1 more source

How do antihypertensive drugs work? Insights from studies of the renal regulation of arterial blood pressure.

Frontiers in Physiology, 2016
Though antihypertensive drugs have been in use for many decades, the mechanisms by which they act chronically to reduce blood pressure remain unclear.
Holly Digne-Malcolm, Matthew Charles Frise, Keith Leonard Dorrington   +2 more
doaj   +1 more source

Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. [PDF]

, 2016
ObjectiveTo compare different blood pressure (BP) levels in their association with the risk of renal outcomes in type 1 diabetes and to determine whether an intensive glycemic control strategy modifies this association.Research design and methodsWe ...
Gitelman, Stephen E, Grimes, Barbara A, Hsu, Chi-Yuan, Ku, Elaine, Mauer, Michael, McCulloch, Charles E   +5 more
core   +2 more sources